Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: $0
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
1 of 5 filings we hold was filed after the two-business-day deadline. The furthest past the deadline was 1 business day late.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured
The 20 most recent Form 4 transactions.
| Mar 1 | ACRS | Aclaris Therapeutics, Inc. | MEXER | 2,375 | — | — | +1.3% | Open the original filing on SEC.gov |
| Feb 3 | ACRS | Aclaris Therapeutics, Inc. | MEXER◆ | 22,025 | — | — | — | Open the original filing on SEC.gov |
| Feb 3 | ACRS | Aclaris Therapeutics, Inc. | FTAX | 6,449 | $3.47 | $22.4K | -3.4% | Open the original filing on SEC.gov |
| Feb 3 | ACRS | Aclaris Therapeutics, Inc. | MEXER | 22,025 | — | — | +12.9% | Open the original filing on SEC.gov |
| Feb 2 | ACRS | Aclaris Therapeutics, Inc. | AGRANT◆ | 346,800 | — | — | — | Open the original filing on SEC.gov |
| Feb 2 | ACRS | Aclaris Therapeutics, Inc. | AGRANT◆ | 99,100 | — | — | — | Open the original filing on SEC.gov |
| Feb 1 | ACRS | Aclaris Therapeutics, Inc. | MEXER◆ | 14,750 | — | — | — | Open the original filing on SEC.gov |
| Feb 1 | ACRS | Aclaris Therapeutics, Inc. | FTAX | 4,984 | $3.51 | $17.5K | -2.9% | Open the original filing on SEC.gov |
| Feb 1 | ACRS | Aclaris Therapeutics, Inc. | MEXER | 14,750 | — | — | +9.2% | Open the original filing on SEC.gov |
| Jan 2 | ACRS | Aclaris Therapeutics, Inc. | MEXER◆ | 13,200 | — | — | — | Open the original filing on SEC.gov |
| Jan 2 | ACRS | Aclaris Therapeutics, Inc. | FTAX | 4,461 | $2.88 | $12.8K | -2.7% | Open the original filing on SEC.gov |
| Jan 2 | ACRS | Aclaris Therapeutics, Inc. | MEXER | 13,200 | — | — | +8.7% | Open the original filing on SEC.gov |
| Jan 1 | ACRS | Aclaris Therapeutics, Inc. | MEXER◆ | 7,500 | — | — | — | Open the original filing on SEC.gov |
| Jan 1 | ACRS | Aclaris Therapeutics, Inc. | FTAX | 2,250 | $3.01 | $6.8K | -1.5% | Open the original filing on SEC.gov |
| Jan 1 | ACRS | Aclaris Therapeutics, Inc. | MEXER | 7,500 | — | — | +5.1% | Open the original filing on SEC.gov |
| Dec 31, 2025 | ACRS | Aclaris Therapeutics, Inc. | MEXER◆ | 73,750 | — | — | — | Open the original filing on SEC.gov |
| Dec 31, 2025 | ACRS | Aclaris Therapeutics, Inc. | FTAX | 19,934 | $3.01 | $60K | -12.0% | Open the original filing on SEC.gov |
| Dec 31, 2025 | ACRS | Aclaris Therapeutics, Inc. | MEXER | 73,750 | — | — | +79.6% | Open the original filing on SEC.gov |